CA2308575A1 - Hyperthermic inducible expression vectors for gene therapy and methods of use thereof - Google Patents
Hyperthermic inducible expression vectors for gene therapy and methods of use thereof Download PDFInfo
- Publication number
- CA2308575A1 CA2308575A1 CA002308575A CA2308575A CA2308575A1 CA 2308575 A1 CA2308575 A1 CA 2308575A1 CA 002308575 A CA002308575 A CA 002308575A CA 2308575 A CA2308575 A CA 2308575A CA 2308575 A1 CA2308575 A1 CA 2308575A1
- Authority
- CA
- Canada
- Prior art keywords
- promoter
- expression
- cell
- expression construct
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6408897P | 1997-11-03 | 1997-11-03 | |
US60/064,088 | 1997-11-03 | ||
PCT/US1998/023387 WO1999023216A2 (en) | 1997-11-03 | 1998-11-03 | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2308575A1 true CA2308575A1 (en) | 1999-05-14 |
Family
ID=22053477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002308575A Abandoned CA2308575A1 (en) | 1997-11-03 | 1998-11-03 | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1029041A2 (ja) |
JP (1) | JP2001521740A (ja) |
KR (1) | KR20010031762A (ja) |
CN (1) | CN1299411A (ja) |
AU (1) | AU1377299A (ja) |
BR (1) | BR9813917A (ja) |
CA (1) | CA2308575A1 (ja) |
IL (1) | IL135943A0 (ja) |
WO (1) | WO1999023216A2 (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19951765A1 (de) * | 1999-10-27 | 2001-05-03 | Thomas Schweder | Wirts-Vektor-Systeme zur Überproduktion von thermolabilen Enzymen psychrophiler Organismen |
US6579522B1 (en) | 2000-06-27 | 2003-06-17 | Genvec, Inc. | Replication deficient adenoviral TNF vector |
US7285414B2 (en) | 2000-09-26 | 2007-10-23 | Emory University | Viruses targeted to hypoxic cells and tissues |
AU2001294793B2 (en) * | 2000-09-26 | 2006-06-29 | Emory University | Viruses targeted to hypoxic cells and tissues |
US20030086903A1 (en) | 2001-11-02 | 2003-05-08 | Genvec, Inc. | Therapeutic regimen for treating cancer |
WO2003106663A1 (ja) | 2002-06-18 | 2003-12-24 | エーザイ株式会社 | 遺伝子治療用初代培養脂肪細胞 |
EP1551443A2 (en) * | 2002-10-14 | 2005-07-13 | DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung | Proteins involved in the regulation of energy homeostasis |
JP2008048601A (ja) * | 2004-06-15 | 2008-03-06 | Nippon Kosei Kagaku Kenkyusho:Kk | 治療に有用な産物の生産法およびシステム |
EP1879622A2 (en) * | 2005-05-03 | 2008-01-23 | Veterinärmedizinische Universität Wien | Permeable capsules |
CA2715080C (en) * | 2007-09-28 | 2021-09-28 | Intrexon Corporation | Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof |
CN103667345B (zh) * | 2013-12-02 | 2015-10-28 | 东南大学 | 一种抗肿瘤基因磁性复合纳米颗粒及制备方法 |
WO2017133175A1 (en) * | 2016-02-04 | 2017-08-10 | Nanjing Legend Biotech Co., Ltd. | Engineered mammalian cells for cancer therapy |
CN108913661A (zh) * | 2018-06-22 | 2018-11-30 | 安徽 | 一种人体研究用造血干细胞的制备和提取方法 |
CN114317588B (zh) * | 2020-09-29 | 2023-06-27 | 中国农业科学院生物技术研究所 | 一种作物高温响应型基因组精准甲基化调控回路 |
IT202200000788A1 (it) * | 2022-01-19 | 2023-07-19 | Bruno Cell S R L | Induzione sensibile alla temperatura del programma miogenico e/o adipogenico in cellule per la produzione di tessuto muscolare e/o adiposo |
CN116536349B (zh) * | 2023-05-22 | 2024-02-20 | 安徽农业大学 | 一种大豆GmMLP34基因在调控植物耐高温性上的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991770A (en) * | 1974-01-24 | 1976-11-16 | Leveen Harry H | Method for treating benign and malignant tumors utilizing radio frequency, electromagnetic radiation |
EP0299127A1 (en) * | 1987-07-16 | 1989-01-18 | IntraCel Corporation | A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein |
EP0455424A3 (en) * | 1990-05-02 | 1992-04-29 | Merck & Co. Inc. | Mammalian inducible promoter cascade system |
FR2717187B1 (fr) * | 1994-03-10 | 1996-05-31 | Transgene Sa | Usage combiné de deux cassettes d'expression pour la production d'une protéine d'intérêt. |
-
1998
- 1998-11-03 KR KR1020007004827A patent/KR20010031762A/ko not_active Application Discontinuation
- 1998-11-03 CN CN98812752A patent/CN1299411A/zh active Pending
- 1998-11-03 WO PCT/US1998/023387 patent/WO1999023216A2/en not_active Application Discontinuation
- 1998-11-03 CA CA002308575A patent/CA2308575A1/en not_active Abandoned
- 1998-11-03 IL IL13594398A patent/IL135943A0/xx unknown
- 1998-11-03 BR BR9813917-7A patent/BR9813917A/pt not_active Application Discontinuation
- 1998-11-03 AU AU13772/99A patent/AU1377299A/en not_active Abandoned
- 1998-11-03 EP EP98957538A patent/EP1029041A2/en not_active Withdrawn
- 1998-11-03 JP JP2000519075A patent/JP2001521740A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1999023216A2 (en) | 1999-05-14 |
JP2001521740A (ja) | 2001-11-13 |
BR9813917A (pt) | 2001-10-30 |
EP1029041A2 (en) | 2000-08-23 |
CN1299411A (zh) | 2001-06-13 |
IL135943A0 (en) | 2001-05-20 |
KR20010031762A (ko) | 2001-04-16 |
AU1377299A (en) | 1999-05-24 |
WO1999023216A3 (en) | 1999-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2308575A1 (en) | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof | |
EP0784693B1 (fr) | Vecteurs viraux pour la therapie genique | |
AU1755299A (en) | Vector for tissue-specific replication and gene expression | |
WO1994012629A9 (en) | Episomal vectors for gene therapy | |
US20070244064A1 (en) | Methods and compositions to induce antitumor response | |
JPH10509880A (ja) | 組織特異的複製のためのベクター | |
JP2004501650A (ja) | 複製欠損アデノウイルスtnfベクター | |
JP2002506651A (ja) | 多重遺伝子ベクター | |
US6709858B1 (en) | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof | |
US7056897B2 (en) | Inducible expression vectors and methods of use thereof | |
ES2268695T3 (es) | Adenovirus recombinantes defectivos con una gen iva2 inactivado. | |
US6451579B1 (en) | Regulated expression of recombinant proteins using RNA viruses | |
Tomita et al. | Gene therapy with transcription factor decoy oligonucleotides as a potential treatment for cardiovascular diseases | |
Kouraklis | Gene therapy for cancer | |
US7098191B2 (en) | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof | |
WO1997016547A1 (en) | ADENOVIRUS-ANTISENSE K-ras EXPRESSION VECTORS AND THEIR APPLICATION IN CANCER THERAPY | |
Palapattu et al. | GENE THERAPY FOR PROSTATE CANCER: New Perspectives on an Old Problem | |
MXPA00004293A (en) | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof | |
WO2000022124A2 (en) | Methods and compositions to induce antitumor response | |
Clayman | Gene therapy for head and neck cancer | |
JP7406263B2 (ja) | 改変アデノウイルス及びこれを含む医薬 | |
JPH10127287A (ja) | 生体内でヒト遺伝子を導入するための新規アデノウィルス・ベクター | |
US5863794A (en) | SV40 viral vectors for targeted integration into cells | |
US20040146856A1 (en) | Anti-neoplastic viral agents | |
FR2737221A1 (fr) | Nouveaux vecteurs viraux pour la therapie genique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |